RecruitingNCT07649031
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
Sponsor
University of Minnesota
Enrollment
80 participants
Start Date
May 25, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying MRIs for people with fanconi anemia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTMRIs
mMRI and ddMRI
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07649031
Related Trials
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
NCT067442831 location
Cancer in Inherited Bone Marrow Failure Syndromes
NCT000272742 locations
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
NCT056871491 location
Investigation of the Genetics of Hematologic Diseases
NCT027206791 location
Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT066480962 locations